Medical Oncology Professionals' Perceptions of Telehealth Video Visits.
Adult
Attitude of Health Personnel
COVID-19
Female
Health Expenditures
Health Services Accessibility
Humans
Male
Medical Oncology
Middle Aged
Nurse Practitioners
Oncologists
Patient Satisfaction
Perception
Physical Examination
Physician Assistants
Physician-Patient Relations
Professional-Patient Relations
Qualitative Research
SARS-CoV-2
Telemedicine
Truth Disclosure
Videoconferencing
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
23
1
2021
Statut:
epublish
Résumé
Telehealth has emerged as a means of improving access and reducing cost for medical oncology care; however, use by specialists prior to the coronavirus disease 2019 (COVID-19) pandemic still remained low. Medical oncology professionals' perceptions of telehealth for cancer care are largely unknown, but are critical to telehealth utilization and expansion efforts. To identify medical oncology health professionals' perceptions of the barriers to and benefits of telehealth video visits. This qualitative study used interviews conducted from October 30, 2019, to March 5, 2020, of medical oncology health professionals at the Thomas Jefferson University Hospital, an urban academic health system in the US with a cancer center. All medical oncology physicians, physicians assistants, and nurse practitioners at the hospital were eligible to participate. A combination of volunteer and convenience sampling was used, resulting in the participation of 29 medical oncology health professionals, including 20 physicians and 9 advanced practice professionals, in semistructured interviews. Medical oncology health professionals' perceptions of barriers to and benefits of telehealth video visits as experienced by patients receiving cancer treatment. Of the 29 participants, 15 (52%) were women and 22 (76%) were White, with a mean (SD) age of 48.5 (12.0) years. Respondents' perceptions were organized using the 4 domains of the National Quality Forum framework: clinical effectiveness, patient experience, access to care, and financial impact. Respondents disagreed on the clinical effectiveness and potential limitations of the virtual physical examination, as well as on the financial impact on patients. Respondents also largely recognized the convenience and improved access to care enabled by telehealth for patients. However, many reported concern regarding the health professional-patient relationship and their limited ability to comfort patients in a virtual setting. Medical oncology health professionals shared conflicting opinions regarding the barriers to and benefits of telehealth in regard to clinical effectiveness, patient experience, access to care, and financial impact. Understanding oncologists' perceptions of telehealth elucidates potential barriers that need to be further investigated or improved for telehealth expansion and continued utilization; further research is ongoing to assess current perceptions of health professionals and patients given the rapid expansion of telehealth during the COVID-19 pandemic.
Identifiants
pubmed: 33443581
pii: 2775074
doi: 10.1001/jamanetworkopen.2020.33967
pmc: PMC7809588
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2033967Références
Eur J Cancer. 2020 Jun;132:136-140
pubmed: 32361628
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Telemed J E Health. 2013 May;19(5):339-45
pubmed: 23289907
Med Clin North Am. 2018 May;102(3):533-544
pubmed: 29650074
Cancer. 2008 Feb 15;112(4):909-18
pubmed: 18189295
Eur Urol. 2015 Oct;68(4):729-35
pubmed: 25900782
Fam Med. 2005 May;37(5):360-3
pubmed: 15883903
Health Aff (Millwood). 2018 Dec;37(12):1923-1930
pubmed: 30633670
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204
Int J Technol Assess Health Care. 2005 Fall;21(4):517-21
pubmed: 16262977
J Clin Oncol. 2001 Apr 1;19(7):2049-56
pubmed: 11283138
J Oncol Pract. 2006 Sep;2(5):228-30
pubmed: 20859340
JAMA Oncol. 2019 Jun 3;:
pubmed: 31158272
JAMA Oncol. 2018 Jun 1;4(6):791-797
pubmed: 29596618
Med J Aust. 2013 Sep 16;199(6):414-7
pubmed: 24033216
Int J Telemed Appl. 2014;2014:143824
pubmed: 25243009
J Oncol Pract. 2018 Oct 24;:JOP1800120
pubmed: 30355027
Telemed J E Health. 2014 Sep;20(9):769-800
pubmed: 24968105
Palliat Support Care. 2017 Jun;15(3):328-335
pubmed: 27804909
JAMA Oncol. 2015 Nov;1(8):1025-6
pubmed: 26270992